Home/Filings/4/0001062993-22-023020
4//SEC Filing

DOyley-Gay Hope 4

Accession 0001062993-22-023020

CIK 0001273636other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 9:15 AM ET

Size

8.0 KB

Accession

0001062993-22-023020

Insider Transaction Report

Form 4
Period: 2022-11-30
DOyley-Gay Hope
General Counsel
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-11-30180,0000 total
    Exercise: $2.02Exp: 2031-12-13Common Stock (180,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-11-30147,9000 total
    Exercise: $0.40Exp: 2032-08-21Common Stock (147,900 underlying)
Footnotes (1)
  • [F1]At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001897964

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:15 AM ET
Size
8.0 KB